About Emedea
Emedea is a Healthcare company based in Italy. Integrated solutions for industrial automation are provided by the company. It operates on a HealthTech model. Its website emedea.it draws about 14 thousand monthly visits. Emedea offers products and services including Neurorehabilitation Services. Its focus areas include Rehabilitation and Pediatric Neurorehabilitation. Its legal entity is Istituto Scientifico per la Neuroriabilitazione in Età Evolutiva.
Company details
Neurorehabilitation services are provided by Emedea for children in developmental age. Focus is placed on pediatric care within the healthcare sector. Specialized solutions are developed to support neurological recovery and development. The institute operates in Italy, addressing specific needs in pediatric neurorehabilitation.
- Headquarters Italy
- SectorsHealthcare
- Website emedea.it
- Legal Name Istituto Scientifico Per La Neuroriabilitazione In Età Evolutiva
- Latest Funding Round$879.93K (USD), Grant
Jan 2020
- Investors
Products & Services of Emedea
Emedea offers a comprehensive portfolio of products and services, including Neurorehabilitation Services.
Neurorehabilitation services are provided for developmental age patients.
Funding Insights of Emedea
- Total Rounds 1
- Last Round Grant — $879,927
- First Round $879,927
(Jan 2020)
- Investors Count 1
All 1 funding rounds of Emedea with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $879,927 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Emedea
Emedea has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Emedea
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Emedea
The website of Emedea (emedea.it) receives about 13.7K visits a month.
- Monthly visits13.7K
▼ 0.5% vs previous month
Websites whose visitors overlap most with Emedea. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neuromed.it | 93% | 49.7K | #672,578 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emedea
Emedea is headquartered in Italy.
Neurorehabilitation services are provided by Emedea for children in developmental age. Focus is placed on pediatric care within the healthcare sector. Specialized solutions are developed to support neurological recovery and development. The institute operates in Italy, addressing specific needs in pediatric neurorehabilitation.
Emedea offers Neurorehabilitation Services.
Emedea has 1 investor. Key investors include European Union.
Emedea operates through Istituto Scientifico Per La Neuroriabilitazione In Età Evolutiva.